• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Food

  • Print
  • Share
  • E-mail

Template for in vitro Bacterial Reverse Mutation (Ames) Test

Introduction to the Template for in vitro Bacterial Reverse Mutation (Ames) Test

March 2004

Return to Toxicology Template Introduction


Table Of Contents

  1. Identification Of Test
  2. Good Laboratory Practice
  3. Materials And Methods
    1. Test Substance
      1. Chemical Name:
      2. Cas Registry Name:
      3. Cas Registry Number:
      4. Structure:
      5. Purity:
      6. Impurities:
      7. Physical Description:
      8. Stability:
      9. Comments:
    2. Test Substance As Administered
      1. Batch/Lot Number:
      2. Vehicle Used:
      3. Tested Adequately For Concentration?
      4. Tested For Stability?
      5. Problems With Storage?
    3. Experimental Methodology
      1. Bacterial Strains Used:
      2. In Vitro Metabolic Activation System (S9 Mix):
      3. Control Agents:
      4. Test Compound Concentrations Used:
      5. Test Procedure Used:
      6. Protocol:
      7. Statistical Analysis:
      8. Evaluation Criteria:
  4. Results
    1. Preliminary Cytotoxicity (Range-Finding) Test
      1. Table 1.  Summary Of Preliminary Cytotoxicity (Range-Finding) Test
      2. Comments On Cytotoxicity (Range-Finding) Test:
    2. Mutation Tests
      1. Table 2.  Summary Of Initial Mutation Test
      2. Comments On Initial Mutation Test:
      3. Table 3.  Summary Of Second (Confirmatory) Mutation Test
      4. Comments On Second Mutation Test:
      5. Table 4.  Summary Of Third (Confirmatory) Mutation Test (Optional):
      6. Comments On Third Mutation Test (Optional):
  5. Overall Assessment And Summary
    1. Assessment Of Study
    2. Summary
  6. References

GENETIC TOXICOLOGY STUDIES:

IN VITRO BACTERIAL REVERSE MUTATION (AMES) TESTS1 

Date of Submission:

Title of Petition or Notification:            

Name and Address of Petitioner or Notifier:       

I.    IDENTIFICATION OF TEST

A.  Test File Location (Volume and Page Number(s)):     
B.  Test Title/Report Number:         
C.  Name of Author or Director of Test:        
D.  Name and Address of Testing Laboratory:       
E.  Date of Test Report:
F.  Dates Test Conducted:         
G. Objective of Test:       
H. Comments:  

II.  GOOD LABORATORY PRACTICE2 

A.  Is a Good Laboratory practice (GLP) Compliance statement included?
B.  Is a Quality Assurance (QA) Statement Included?    
C.  Availability and Location of Original Data/Specimens/Test Substance:

III. MATERIALS AND METHODS

A.   TEST SUBSTANCE

  1. Chemical Name:            
  2. CAS Registry Name:    
  3. CAS Registry Number:           
  4. Structure: 3            
  5. Purity:          
  6. Impurities:              
  7. Physical Description:         
  8. Stability:    
  9. Comments:            

B.   TEST SUBSTANCE AS ADMINISTERED4 

  1. Batch/Lot Number:   
  2. Vehicle Used:      
  3. Tested for Concentration?      
  4. Tested for Stability?         
  5. Problems with Storage?            

 

C.   EXPERIMENTAL METHODOLOGY5

1.        Bacterial Strains Used6 :    

a.             Salmonella Typhimurium:       

 TA98 TA100 TA1535 TA1537
 TA97 TA97a TA1538 TA102
   Other S. Typhimurium strains (specify):          

 

b.             Escherichia Coli:

 WP2(uvrA)
 Other E. coli strains (specify):

 

c.              Were the Strains:           

Checked for appropriate genetic markers?7  Yes No or not stated
Properly maintained? Yes No or not stated

 

2.        In Vitro Metabolic Activation System (s9 Mix):         

a            Composition: 8           

COMPONENT

CONCENTRATION OR AMOUNT (Unit)

COMMENT

   
   
   
S9 Fraction
(Details on induction, see below)
  

 

b.             S9 Fraction:

INDUCED

OR NOT

INDUCER USED

ANIMAL

INDUCED*

ANIMAL TISSUE USED FOR S9 FRACTION

 Induced Aroclor 1254 Rat Liver
   Phenobarbital Mouse Lung
   

Other (specify):

 

 Hamster 

Other (specify):

 

     

Other (specify):

 

  
 Non-induced None None None

* Specify strain and sex of the animal induced:  Strain:                    Sex:     

 

3.        control agents:                      

a.             Negative Control:          
b.             Solvent/Final Concentration:      
c.              Positive Controls Without Metabolic Activation9 :        

TESTER STRAINS10 

CHEMICAL

DOSE (mg/PLATE)

   
   
   
   
   
   

d.             Positive Controls with Metabolic Activation:    

TESTER STRAINS

CHEMICAL

DOSE (mg/PLATE)

   
   
   

e.             Comments on Positive Controls:

4.        Test Compound Concentrations Used:      

a.             Preliminary Cytotoxicity/Range-Finding Test:11    

CONDITION

TEST COMPOUND

CONCENTRATION/SOLVENT

NON-ACTIVATED (-S9)  
ACTIVATED         (+S9)  

 

b.             Mutagenicity Test(s)12 :               

CONDITION

TEST COMPOUND

CONCENTRATION/SOLVENT

INITIAL

 

- S9  

 

 

+S9  
Second Confirmatory- S9  

 

 

+S9  
Third Confirmatory- S9  

 

 

+S9  

5.         Test Procedure Used:         

 Standard plate incorporation test
 Preincubation testTime:Temperature:
 Other (describe)

6.         Protocol13 :              

 

 

7.        Statistical Analysis14 :           

 

 

8.        Evaluation Criteria15 :            

 

 

III. RESULTS

A.   PRELIMINARY CYTOTOXICITY (RANGE-FINDING) TEST 16 

1.       Table 1.  Summary of Preliminary Cytotoxicity (Range-Finding)Test

STRAIN

S9

DOSE RANGE (mg/PLATE)

HIGHEST
MEAN NUMBER REVERTANTS /PLATE
(AT DOSE?)

BACKGROUND LAWN17 

HISTORICAL CONTROL RANGE

TA100-    
TA100-Solvent control   
TA100-Positive control   
TA100+    
TA100+Solvent control   
TA100+Positive control   
WP2 (uvrA)-    
WP2 (uvrA)-Solvent control   
WP2 (uvrA)-Positive control   
WP2 (uvrA)+    
WP2 (uvrA)+Solvent control   
WP2 (uvrA)+Positive control   

 

2.        Comments on Cytotoxicity (Range-Finding) Test18 :    

B.   MUTATION TESTS19      

1.        Table 2.  Summary of Initial Mutation Test     

STRAIN

S9

DOSE RANGE (mg/PLATE)

HIGHEST
MEAN NUMBER REVERTANTS /PLATE
(AT DOSE?)

BACKGROUND LAWN20 

DOSE RESPONSE?

TA98-    
TA98-Solvent control   
TA98-Positive control  
TA98+    
TA98+Solvent control   
TA98+Positive control  
TA100-    
TA100-Solvent control   
TA100-Positive control  
TA100+    
TA100+Solvent control   
TA100+Positive control  
TA1535-    
TA1535-Solvent control   
TA1535-Positive control  
TA1535+    
TA1535+Solvent control   
TA1535+Positive control  
TA1537-    
TA1537-Solvent control   
TA1537-Positive control  
TA1537+    
TA1537+Solvent control   
TA1537+Positive control  
WP2 (uvrA)-    
WP2 (uvrA)-Solvent control   
WP2 (uvrA)-Positive control  
WP2 (uvrA)+    
WP2 (uvrA)+Solvent control   
WP2 (uvrA)+Positive control  

2.        Comments on Initial Mutation Test:21          

3.        Table 3.  Summary of Second (Confirmatory) Mutation Test         

STRAIN

S9

DOSE RANGE (mg/PLATE)

HIGHEST

MEAN NUMBER REVERTANTS /PLATE

(AT DOSE?)

BACKGROUND LAWN22 

DOSE RESPONSE?

TA98-    
TA98-Solvent control   
TA98-Positive control  
TA98+    
TA98+Solvent control   
TA98+Positive control  
TA100-    
TA100-Solvent control   
TA100-Positive control  
TA100+    
TA100+Solvent control   
TA100+Positive control  
TA1535-    
TA1535-Solvent control   
TA1535-Positive control  
TA1535+    
TA1535+Solvent control   
TA1535+Positive control  
TA1537-    
TA1537-Solvent control   
TA1537-Positive control  
TA1537+    
TA1537+Solvent control   
TA1537+Positive control  
WP2 (uvrA)-    
WP2 (uvrA)-Solvent control   
WP2 (uvrA)-Positive control  
WP2 (uvrA)+    
WP2 (uvrA)+Solvent control   
WP2 (uvrA)+Positive control  

 

4.        Comments on Second Mutation Test:23         

5.         Table 4.  Summary of Third (Confirmatory) Mutation Test (Optional)24 :

STRAIN

S9

DOSE RANGE (mg/PLATE)

HIGHEST
MEAN NUMBER REVERTANTS /PLATE
(AT DOSE?)

BACKGROUND LAWN25 

DOSE RESPONSE?

TA98-    
TA98-Solvent control   
TA98-Positive control  
TA98+    
TA98+Solvent control   
TA98+Positive control  
TA100-    
TA100-Solvent control   
TA100-Positive control  
TA100+    
TA100+Solvent control   
TA100+Positive control  
TA1535-    
TA1535-Solvent control   
TA1535-Positive control  
TA1535+    
TA1535+Solvent control   
TA1535+Positive control  
TA1537-    
TA1537-Solvent control   
TA1537-Positive control  
TA1537+    
TA1537+Solvent control   
TA1537+Positive control  
WP2 (uvrA)-    
WP2 (uvrA)-Solvent control   
WP2 (uvrA)-Positive control  
WP2 (uvrA)+    
WP2 (uvrA)+Solvent control   
WP2 (uvrA)+Positive control  

 

6.         Comments on Third Mutation Test (Optional):          

V.   OVERALL ASSESSMENT AND SUMMARY

A.   ASSESSMENT OF STUDY  
B.   SUMMARY

VI. REFERENCES


End Notes

This section includes some comments that are only relevant when using the Word template.

 

 1FDA's recommendations for conducting a bacterial reverse mutation test are contained in Redbook 2000, IV.C.1.a. Bacterial Reverse Mutation Test http://www.cfsan.fda.gov/~redbook/redivc1a.html.  This template is for the S. typhimurium  Test (Ames Test), the most commonly used reverse mutation test.  In addition to the S. typhimurium  TA strains, an E. coli strain WP2 or its variants are often included in the test.  The TA strains detect a reversion event from Histidine dependence to Histidine independence while the WP2 strains do the same for Tryptophan dependence.

 

 2Indicate Yes or No for the Questions A and B.  However, you may want to elaborate on the type of GLP compliance (USFDA, OECD, etc.) or make other notations.

 

 3 If the molecular structure is not provided with the test, it may be available from a source such as Chemfinder (http://www.chemfinder.com) or ChemIDplus (http://chem.sis.nlm.nih.gov/chemidplus/).  The CAS number is the preferred search term if you have it, otherwise try the common name or any synonyms. If the correct structure is found on Chemfinder or ChemIDplus, the image can be downloaded and inserted into your report.  If the structure is not available, enter 'Not available'.

 

 4Indicate how the test substance was administered and whether any vehicle was used to dissolve/suspend the test substance (e.g., dissolved in dimethylsulfoxide).  Describe how testings for concentration and stability were done.  How was the test substance in vehicle, etc., stored before being used in the test? Note anything that was not normal or routine.

 

 5Provide adequate details so the information can be used to help prepare a report. Use the comments to indicate additional information about the experimental design.  To change the table, place cursor in the row or column that you wish to modify, then from the 'Table' menu, use 'Select Row' or 'Select Column' to highlight the row or column that you wish to change, and use the 'delete' or 'insert' functions to make your changes.

 

 6Put an X in the box to the left of each strain used and type in any other strain used.

 

 7e.g. rfa mutations, R factor

 

 8List the components and concentrations of cofactor solutions as well as the amount of S9 fraction in S9 mix.  If the S9 mix was purchased, provide details.

 


 9Enter all strains treated with a given positive control at the same dose.  If a given positive control agent was used at different doses in different strains, add a separate row for each dose.  If all table rows are used, add additional rows by clicking the left mouse button in the last cell (bottom right) and pressing the TAB key.

 

 10Frequently 2-Aminoanthracene (2-Anthramine) is used as the positive control without activation in all tester strains. If this is the case, just enter "All Strains", otherwise enter the individual strains treated with a given positive control at the same dose.

 

 11If no preliminary cytotoxicity test was performed, enter "not performed."

 

 12If more than one mutagenicity test was conducted, list the concentrations used in each test.

 

 13Give a brief description of the experimental protocol including tester strain preparation, media used, cell numbers, number of plates/dose/activation condition, incubation times and colony counting method.

 

 14Briefly describe the method used.  Usually in the Salmonella test, the criterion for a positive response is given as a fold-increase over the solvent control (two- or three-fold increase depending on the strain) and no statistical analysis is used. In that case, just enter "not conducted."

 

 15Enter the criteria for an acceptable test and for a positive and negative response.  Were the revertant colonies counted with an automatic counter or manually?

 

 16TA100 and WP2 (uvrA) are frequently used in the cytotoxicity test; however, if other strains were used, modify the table as required using the standard Word commands.

 

 17e.g. normal, thin, absent

 

 18Briefly describe the results of the cytotoxicity (range-finding) test and the basis for the selection of concentrations used in the mutation tests.  For example, "in the absence of any cytotoxic effect, the limit dose of 5 mg/plate was used as the upper dose" or "the upper dose was limited by cytotoxicity or solubility".

 

 19The five most commonly used tester strains are entered in the table as defaults; however, the table should be modified to reflect the strains actually used in a given test.

 

 20Enter the description of the background lawn: e.g. normal, thin, absent.

 

 21Briefly summarize the results of the mutation test with the goal of clarifying or expanding on the data in the table or adding something pertinent not included in the table.  For example, comments such as the following could be included: 

  • Cytotoxicity as based on a reduction in the background number of revertants per plate was seen in strain(s) at dose(s) of X - Y. 
  • A precipitate was seen at concentrations of X and above.
  • A two-fold or greater increase in the number of revertants/plate was seen in strain(s) at X mg/plate.
  • A mutagenic effect was seen only in strain(s) indicating a frameshift method of action.
  • The positive and solvent control values were appropriate for the respective strains.
  • Based on results of the first mutation test, test material concentrations of X - Y were chosen for the second mutation test.

Essentially, this summary is a statement of conclusions drawn from the test.

 

 22Enter the description of the background lawn: e.g. normal, thin, absent.

 

 23Briefly summarize the second test as you did the first test. Do the results of the second test agree or disagree with those of the first test?

 

 24Delete the table and sections III.B.5-6 if not needed. 

 

 25Enter the description of the background lawn: e.g. normal, thin, absent.

 


Some of the internet links may have been changed in this document. Guidance documents can be found in the guidance area of the Food section of www.fda.gov

 

(Return to Toxicology Template Introduction)

Top